Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. - Wikidata - awgldk - TriplyDB

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

http://www.wikidata.org/entity/Q37273037

about

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions HIV-1 diversity, transmission dynamics and primary drug resistance in Angola Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya Rapid disease progression in HIV-1 subtype C-infected South African women.Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission.Predicting time to threshold for initiating antiretroviral treatment to evaluate cost of treatment as HIV prevention HIV-1 replication capacity: Setting the pace of disease.HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data.High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples.Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries.Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.No Evidence for Association of β-Defensin Genomic Copy Number with HIV Susceptibility, HIV Load during Clinical Latency, or Progression to AIDS.A novel approach to estimation of the time to biomarker threshold: applications to HIV.Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs.Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.HIV transmission clusters among injecting drug users in Romania.Immunogenetic Factors in Early Immune Control of Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Evaluation of HLA Class I Amino Acid Variants in Two African Populations Conserved HIV Epitopes for an Effective HIV Vaccine.Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples.Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa.Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997)

P2860

Q28391986-B1F5E389-610D-4E76-A96D-338227A1FA17 Q28542528-75B6F868-EFFE-4988-A52F-1AFA35D80EA1 Q33654658-A3239FF1-447D-4EB9-95D3-33ED8247EEC5 Q33878681-7CDEC9CD-393C-47FA-B926-498FC39C5FF0 Q34736181-93355F29-A00C-4AB7-B666-10372D847511 Q34989509-8057CD5A-CA90-44F2-B6C8-6247E2B61460 Q34999494-89F68331-48DE-4891-AD82-0B155C320092 Q35229572-C7F9FAC4-57B2-4779-9865-93E28F3E2A86 Q35588137-54FD5977-86FB-47A8-B36E-DFB5925CBD7C Q35588149-875821BF-07CE-4EF9-B8F6-9D3647CC131C Q35697246-8548BA1F-EA7F-4E6A-A033-71D6A22D6121 Q35751134-647953DB-0E59-4AA2-B45F-EC63FFEAF642 Q35894094-68C84E6C-9108-49F8-84CE-B9F58B9AB76A Q36194234-FDEE0349-E255-47D8-817E-1B5B32A27DE0 Q36282724-45873720-30DA-425E-8B15-16CE651AF6C6 Q37220730-11CCEA8A-DF53-4763-ABA0-09595AF5C302 Q37597093-3854DDFC-541D-43C6-A765-0A15648EC380 Q37604707-D041E5E7-6B44-4FB1-8B27-C67732CB5D32 Q37619260-AED00385-5C89-498A-9EE9-D38A6B31C2E7 Q38706845-82B816F3-86C7-4465-B0C2-F68EBD92C04C Q39022805-7BD3599F-6935-4B63-893E-60DCF669DCB4 Q39388941-ADA76DC3-6B73-41A8-AD50-3C4D49A32B30 Q40860723-2C008A93-6DDC-4C90-8C25-8F5C1F6F815E Q46091440-9E7801FE-BE30-4C13-B69F-8B5C6B3F6177 Q46154899-897BC415-F82F-40F9-B559-3F9D71772F10 Q46552325-DEC7A1D3-4F5D-4921-AAF5-45AEDA081E29 Q47011252-4FA9AA8A-1204-414A-B9BA-5B2DBF75F8B0 Q47093684-4A729F55-822D-49E9-8E1F-BDE91B65ADA9 Q50351069-4A18E54D-A378-4889-A611-250FBF44F014 Q52610202-23ED102A-7574-473B-8657-70A06581D078 Q54215604-D60CE9F9-495C-4E4D-A875-19667B76F766 Q58742287-BAFFE64F-5DFF-48E3-9D31-9A3CB2D15ECE

P2860

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

http://www.wikidata.org/entity/Q37273037

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@en

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@nl

type

label

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@en

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@nl

prefLabel

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@en

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@nl

P1433

Q37273037-8FC29E9A-BDC9-477B-A99C-9A6F3730A166

P1476

Q37273037-CDAB5D9A-DD3D-4864-9E22-FD0DCCABE361

P2093

Q37273037-30B49AF7-144E-4A39-890E-6DBE424B59D8

Q37273037-35CF463A-95D0-40A3-92BE-9D93EA5AA8C5

Q37273037-5B0CD46F-4183-41D8-BEC3-A2DFE383F0C3

Q37273037-6356A8C6-5DC3-4947-A3F5-9F36E475E225

Q37273037-7C28F1A7-2CB9-4A0B-9304-A0FEEE3CF352

Q37273037-A0E3FAB2-488B-48EF-9677-40806D48375A

Q37273037-A95DBAA4-B3B4-4D23-911D-4305BCEFAEC9

Q37273037-AF4CEFC5-08DA-40DC-9FF5-2BB3F3A7BE9A

Q37273037-AF9149AB-915B-4135-8A8D-7224E95A8328

Q37273037-F13862B5-6A42-4862-8F35-03E98F6FBE4F

P2860

Q37273037-01D22204-A53E-49D0-8DB4-3C3DDE4931E3

Q37273037-149547E0-51B9-4D11-AB29-6FDAB47E048F

Q37273037-27160E94-A01D-474A-82E4-D87E309CF686

Q37273037-39273E6C-B023-4971-A56B-4BD010531307

Q37273037-3D9F4179-7A61-40F4-9282-22C29424B5FC

Q37273037-404E7431-6DE9-4D99-91CA-00A2E64FCA18

Q37273037-548A2556-0C12-4B49-BAE4-BECF363FBD00

Q37273037-613D8FC8-0125-4B89-9FE5-357AE19F50DD

Q37273037-67E8D24C-ABED-4EEB-BB16-CE5D69F99732

Q37273037-6D5C251D-959C-4BBD-B017-371E8A64A493

P304

Q37273037-4F303E37-D8E5-4DE7-BA67-F20F5E1B75E1

P31

Q37273037-C3C2291F-F204-4CEE-B8C3-067274DDEBDA

P356

Q37273037-A36AFBB5-47F2-4124-A441-F0E7F3F034DD

P407

Q37273037-BE399EC0-3C55-44F3-8CEA-7CD51078D880

P433

Q37273037-FD7C6271-1155-43D5-97E7-6A8588E3338E

P478

Q37273037-E4053C3A-290E-438F-9A96-CA6D54729AE6

P50

Q37273037-081C9AFE-48AC-4320-9E14-E7B134A1382B

Q37273037-398E7E59-E92A-464D-9A6C-01C77934FBA1

Q37273037-4C288014-90A2-42EA-8FEA-5345B6D1D5EE

Q37273037-961D3C64-20F3-46EF-B933-4AC491F3F847

Q37273037-9AC6CE62-7C7D-4DB9-AAED-D51E6C694C00

Q37273037-AB775933-EFDC-4494-8F1D-714B358B37C4

P577

Q37273037-A7882C4A-9F27-49C3-8DF4-94E7B40964CC

P5875

Q37273037-74E7DB45-C6FB-4747-8C33-8024F09F3973

P698

Q37273037-63D021EC-96D2-452B-B222-15AADCB178A5

P921

Q37273037-5919BD26-4FA0-4B68-90D6-FAA527BA4BC2

Q37273037-728B9540-20EB-4FE3-A23F-344867E414FB

P932

Q37273037-11628B40-CB4B-48DE-B67E-1BF3E5210F1C

P356

QAD.0000000000000012

P1433

P1476

Disease progression by infecti ...... cohort in sub-Saharan Africa.

@en

P2093

Emmanuel Cormier

http://www.w3.org/2001/XMLSchema#string

IAVI Africa HIV Prevention Partnership

http://www.w3.org/2001/XMLSchema#string

Jill Gilmour

http://www.w3.org/2001/XMLSchema#string

Mary H Latka

http://www.w3.org/2001/XMLSchema#string

Patricia E Fast

http://www.w3.org/2001/XMLSchema#string

Pauli N Amornkul

http://www.w3.org/2001/XMLSchema#string

Shabir Lakhi

http://www.w3.org/2001/XMLSchema#string

Susan A Allen

http://www.w3.org/2001/XMLSchema#string

Wasima N Rida

http://www.w3.org/2001/XMLSchema#string

William Kilembe

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Slower heterosexual spread of HIV-2 than HIV-1.

Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya

Human immunodeficiency viruses in the developing world.

HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.

P304

2775-2786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000000012

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Eduard J Sanders

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257647515

http://www.w3.org/2001/XMLSchema#string

P698

24113395

http://www.w3.org/2001/XMLSchema#string

P921

Sub-Saharan Africa

P932

3815107

http://www.w3.org/2001/XMLSchema#string